Copyright Reports & Markets. All rights reserved.

Global Pneumococcal Polysaccharide Vaccine Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Pneumococcal Polysaccharide Vaccine Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Pneumococcal Polysaccharide Vaccine Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Type
    • 1.4.2 Single Dose Vial
    • 1.4.3 Pre-Filled Syringe
  • 1.5 Market by Application
    • 1.5.1 Global Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Application
    • 1.5.2 Children (2-10 Age)
    • 1.5.3 Adult (10-64 Age)
    • 1.5.4 Geriatric (More Than 65 Age)
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Pneumococcal Polysaccharide Vaccine Market Size, Estimates and Forecasts
    • 2.1.1 Global Pneumococcal Polysaccharide Vaccine Revenue 2015-2026
    • 2.1.2 Global Pneumococcal Polysaccharide Vaccine Sales 2015-2026
  • 2.2 Global Pneumococcal Polysaccharide Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Pneumococcal Polysaccharide Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Pneumococcal Polysaccharide Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Pneumococcal Polysaccharide Vaccine Competitor Landscape by Players

  • 3.1 Pneumococcal Polysaccharide Vaccine Sales by Manufacturers
    • 3.1.1 Pneumococcal Polysaccharide Vaccine Sales by Manufacturers (2015-2020)
    • 3.1.2 Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Pneumococcal Polysaccharide Vaccine Revenue by Manufacturers
    • 3.2.1 Pneumococcal Polysaccharide Vaccine Revenue by Manufacturers (2015-2020)
    • 3.2.2 Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Pneumococcal Polysaccharide Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Pneumococcal Polysaccharide Vaccine Revenue in 2019
    • 3.2.5 Global Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Pneumococcal Polysaccharide Vaccine Price by Manufacturers
  • 3.4 Pneumococcal Polysaccharide Vaccine Manufacturing Base Distribution, Product Types
    • 3.4.1 Pneumococcal Polysaccharide Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Pneumococcal Polysaccharide Vaccine Product Type
    • 3.4.3 Date of International Manufacturers Enter into Pneumococcal Polysaccharide Vaccine Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Pneumococcal Polysaccharide Vaccine Market Size by Type (2015-2020)
    • 4.1.1 Global Pneumococcal Polysaccharide Vaccine Sales by Type (2015-2020)
    • 4.1.2 Global Pneumococcal Polysaccharide Vaccine Revenue by Type (2015-2020)
    • 4.1.3 Pneumococcal Polysaccharide Vaccine Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Pneumococcal Polysaccharide Vaccine Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Pneumococcal Polysaccharide Vaccine Revenue Forecast by Type (2021-2026)
    • 4.2.3 Pneumococcal Polysaccharide Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Pneumococcal Polysaccharide Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Pneumococcal Polysaccharide Vaccine Market Size by Application (2015-2020)
    • 5.1.1 Global Pneumococcal Polysaccharide Vaccine Sales by Application (2015-2020)
    • 5.1.2 Global Pneumococcal Polysaccharide Vaccine Revenue by Application (2015-2020)
    • 5.1.3 Pneumococcal Polysaccharide Vaccine Price by Application (2015-2020)
  • 5.2 Pneumococcal Polysaccharide Vaccine Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Pneumococcal Polysaccharide Vaccine Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Pneumococcal Polysaccharide Vaccine Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Pneumococcal Polysaccharide Vaccine by Country
    • 6.1.1 North America Pneumococcal Polysaccharide Vaccine Sales by Country
    • 6.1.2 North America Pneumococcal Polysaccharide Vaccine Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Type
  • 6.3 North America Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Pneumococcal Polysaccharide Vaccine by Country
    • 7.1.1 Europe Pneumococcal Polysaccharide Vaccine Sales by Country
    • 7.1.2 Europe Pneumococcal Polysaccharide Vaccine Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Type
  • 7.3 Europe Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Pneumococcal Polysaccharide Vaccine by Region
    • 8.1.1 Asia Pacific Pneumococcal Polysaccharide Vaccine Sales by Region
    • 8.1.2 Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Type
  • 8.3 Asia Pacific Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Pneumococcal Polysaccharide Vaccine by Country
    • 9.1.1 Latin America Pneumococcal Polysaccharide Vaccine Sales by Country
    • 9.1.2 Latin America Pneumococcal Polysaccharide Vaccine Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Type
  • 9.3 Central & South America Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Pneumococcal Polysaccharide Vaccine by Country
    • 10.1.1 Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales by Country
    • 10.1.2 Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Type
  • 10.3 Middle East and Africa Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Merck & Co., Inc.
    • 11.1.1 Merck & Co., Inc. Corporation Information
    • 11.1.2 Merck & Co., Inc. Description and Business Overview
    • 11.1.3 Merck & Co., Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Merck & Co., Inc. Pneumococcal Polysaccharide Vaccine Products Offered
    • 11.1.5 Merck & Co., Inc. Related Developments
  • 11.2 Pfizer Inc.
    • 11.2.1 Pfizer Inc. Corporation Information
    • 11.2.2 Pfizer Inc. Description and Business Overview
    • 11.2.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Pfizer Inc. Pneumococcal Polysaccharide Vaccine Products Offered
    • 11.2.5 Pfizer Inc. Related Developments
  • 11.3 Glaxosmithkline Plc.
    • 11.3.1 Glaxosmithkline Plc. Corporation Information
    • 11.3.2 Glaxosmithkline Plc. Description and Business Overview
    • 11.3.3 Glaxosmithkline Plc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Glaxosmithkline Plc. Pneumococcal Polysaccharide Vaccine Products Offered
    • 11.3.5 Glaxosmithkline Plc. Related Developments
  • 11.4 Sanofi Pasteur
    • 11.4.1 Sanofi Pasteur Corporation Information
    • 11.4.2 Sanofi Pasteur Description and Business Overview
    • 11.4.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Products Offered
    • 11.4.5 Sanofi Pasteur Related Developments
  • 11.5 China National Biotec Group
    • 11.5.1 China National Biotec Group Corporation Information
    • 11.5.2 China National Biotec Group Description and Business Overview
    • 11.5.3 China National Biotec Group Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 China National Biotec Group Pneumococcal Polysaccharide Vaccine Products Offered
    • 11.5.5 China National Biotec Group Related Developments
  • 11.6 Astellas Pharma Inc
    • 11.6.1 Astellas Pharma Inc Corporation Information
    • 11.6.2 Astellas Pharma Inc Description and Business Overview
    • 11.6.3 Astellas Pharma Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Astellas Pharma Inc Pneumococcal Polysaccharide Vaccine Products Offered
    • 11.6.5 Astellas Pharma Inc Related Developments
  • 11.7 Serum Institute of India Pvt. Ltd
    • 11.7.1 Serum Institute of India Pvt. Ltd Corporation Information
    • 11.7.2 Serum Institute of India Pvt. Ltd Description and Business Overview
    • 11.7.3 Serum Institute of India Pvt. Ltd Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Serum Institute of India Pvt. Ltd Pneumococcal Polysaccharide Vaccine Products Offered
    • 11.7.5 Serum Institute of India Pvt. Ltd Related Developments
  • 11.8 MSD
    • 11.8.1 MSD Corporation Information
    • 11.8.2 MSD Description and Business Overview
    • 11.8.3 MSD Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 MSD Pneumococcal Polysaccharide Vaccine Products Offered
    • 11.8.5 MSD Related Developments
  • 11.1 Merck & Co., Inc.
    • 11.1.1 Merck & Co., Inc. Corporation Information
    • 11.1.2 Merck & Co., Inc. Description and Business Overview
    • 11.1.3 Merck & Co., Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Merck & Co., Inc. Pneumococcal Polysaccharide Vaccine Products Offered
    • 11.1.5 Merck & Co., Inc. Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Pneumococcal Polysaccharide Vaccine Market Estimates and Projections by Region
    • 12.1.1 Global Pneumococcal Polysaccharide Vaccine Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Pneumococcal Polysaccharide Vaccine Revenue Forecast by Regions 2021-2026
  • 12.2 North America Pneumococcal Polysaccharide Vaccine Market Size Forecast (2021-2026)
    • 12.2.1 North America: Pneumococcal Polysaccharide Vaccine Sales Forecast (2021-2026)
    • 12.2.2 North America: Pneumococcal Polysaccharide Vaccine Revenue Forecast (2021-2026)
    • 12.2.3 North America: Pneumococcal Polysaccharide Vaccine Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Pneumococcal Polysaccharide Vaccine Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Pneumococcal Polysaccharide Vaccine Sales Forecast (2021-2026)
    • 12.3.2 Europe: Pneumococcal Polysaccharide Vaccine Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Pneumococcal Polysaccharide Vaccine Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Pneumococcal Polysaccharide Vaccine Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Pneumococcal Polysaccharide Vaccine Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Pneumococcal Polysaccharide Vaccine Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Pneumococcal Polysaccharide Vaccine Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Pneumococcal Polysaccharide Vaccine Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Pneumococcal Polysaccharide Vaccine Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Pneumococcal Polysaccharide Vaccine Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Pneumococcal Polysaccharide Vaccine Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Pneumococcal Polysaccharide Vaccine Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Pneumococcal Polysaccharide Vaccine Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Pneumococcal Polysaccharide Vaccine Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Pneumococcal Polysaccharide Vaccine Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Pneumococcal Polysaccharide Vaccine Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Pneumococcal Polysaccharide Vaccine Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Pneumococcal Polysaccharide Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pneumococcal Polysaccharide Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Pneumococcal Polysaccharide Vaccine market is segmented into
    Single Dose Vial
    Pre-Filled Syringe

    Segment by Application, the Pneumococcal Polysaccharide Vaccine market is segmented into
    Children (2-10 Age)
    Adult (10-64 Age)
    Geriatric (More Than 65 Age)

    Regional and Country-level Analysis
    The Pneumococcal Polysaccharide Vaccine market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Pneumococcal Polysaccharide Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Pneumococcal Polysaccharide Vaccine Market Share Analysis
    Pneumococcal Polysaccharide Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pneumococcal Polysaccharide Vaccine business, the date to enter into the Pneumococcal Polysaccharide Vaccine market, Pneumococcal Polysaccharide Vaccine product introduction, recent developments, etc.

    The major vendors covered:
    Merck & Co., Inc.
    Pfizer Inc.
    Glaxosmithkline Plc.
    Sanofi Pasteur
    China National Biotec Group
    Astellas Pharma Inc
    Serum Institute of India Pvt. Ltd
    MSD

    Buy now